GlassScriptPhysician profile
Susan M Weil
NPI 1174685762
$1,062.78
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $242 · 2021: $619 · 2022: $54.20.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $524.83 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $137.62 | 2019-2020 | |
| Abbvie INC. | $104.07 | 2019-2021 | |
| Myovant Sciences INC. | $77.49 | 2021 | |
| Therapeuticsmd, INC. | $70.76 | 2020-2021 | |
| Radius Health, INC. | $54.10 | 2020-2021 | |
| Millicent US INC | $31.57 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $21.79 | 2021 | |
| Coopersurgical, INC. | $15.96 | 2022 | |
| Hologic Sales and Service, LLC | $13.23 | 2020 | |
| Evofem Biosciences, INC. | $11.36 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Weil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.